George W. Hebard III, M.B.A.
— Interim Principal Executive Officer, Chief Operating Officer and Principal Financial Officer
Mr. Hebard was appointed Interim Principal Executive Officer and Chief Operating Officer in May 2012, and Principal Financial Officer in August 2013. He joined Enzon as a director of the Company on February 27, 2012. From September 2011 to April 2012, Mr. Hebard was a Managing Director at Icahn Capital LP, the entity through which Carl C. Icahn manages investment funds. Prior to joining Mr. Icahn, from 2005 to 2011, Mr. Hebard served as a Managing Director at Blue Harbour Group, an investment firm in Greenwich, Connecticut. Prior to Blue Harbour Group, Mr. Hebard served as a Managing Director at Ranger Partners from 2002 to 2003, and prior to Ranger Partners, Mr. Hebard was an Associate at Icahn Associates Corp. from 1998 to 2002. He has an MBA from INSEAD and an A.B. in Economics from Princeton University.
Andrew Rackear, J.D.
— Vice President and General Counsel
Andrew Rackear has served as Enzon’s general counsel and secretary since April 2010, and also as chief compliance officer since September 2010. Prior to joining Enzon, Mr. Rackear served as senior vice president and general counsel for NPS Pharmaceuticals, and vice president and general counsel for Chugai Pharma USA and Amersham Biosciences Corp, where he also served as president of North American operations.
Prior to joining the industry, Mr. Rackear engaged in litigation and commercial law practice at Marks & Murase (now Bingham McCutchen) and served as associate general counsel at Sharp Electronics Corp. Mr. Rackear holds a J.D. from New York University School of Law.